Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Artificial Organ And Bionics Market, by Product
1.4.2 North America Artificial Organ And Bionics Market, by Technology
1.4.3 North America Artificial Organ And Bionics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Artificial Organ And Bionics Market by Product
3.1 North America Artificial Organs Market by Country
3.2 North America Artificial Organ And Bionics Market by Artificial Organs Type
3.2.1 North America Kidney Market by Country
3.2.2 North America Heart Market by Country
3.2.3 North America Lungs Market by Country
3.2.4 North America Liver Market by Country
3.2.5 North America Pancreas Market by Country
3.3 North America Artificial Bionics Market by Country
3.4 North America Artificial Organ And Bionics Market by Artificial Bionics Type
3.4.1 North America Cochlear Implant Market by Country
3.4.2 North America Bionic limbs Market by Country
3.4.3 North America Exoskeleton Market by Country
3.4.4 North America Vision bionics Market by Country
3.4.5 North America Brain bionics Market by Country
Chapter 4. North America Artificial Organ And Bionics Market by Technology
4.1 North America Mechanical Market by Country
4.2 North America Electronic Market by Country
Chapter 5. North America Artificial Organ And Bionics Market by Country
5.1 US Artificial Organ And Bionics Market
5.1.1 US Artificial Organ And Bionics Market by Product
5.1.1.1 US Artificial Organ And Bionics Market by Artificial Organs Type
5.1.1.2 US Artificial Organ And Bionics Market by Artificial Bionics Type
5.1.2 US Artificial Organ And Bionics Market by Technology
5.2 Canada Artificial Organ And Bionics Market
5.2.1 Canada Artificial Organ And Bionics Market by Product
5.2.1.1 Canada Artificial Organ And Bionics Market by Artificial Organs Type
5.2.1.2 Canada Artificial Organ And Bionics Market by Artificial Bionics Type
5.2.2 Canada Artificial Organ And Bionics Market by Technology
5.3 Mexico Artificial Organ And Bionics Market
5.3.1 Mexico Artificial Organ And Bionics Market by Product
5.3.1.1 Mexico Artificial Organ And Bionics Market by Artificial Organs Type
5.3.1.2 Mexico Artificial Organ And Bionics Market by Artificial Bionics Type
5.3.2 Mexico Artificial Organ And Bionics Market by Technology
5.4 Rest of North America Artificial Organ And Bionics Market
5.4.1 Rest of North America Artificial Organ And Bionics Market by Product
5.4.1.1 Rest of North America Artificial Organ And Bionics Market by Artificial Organs Type
5.4.1.2 Rest of North America Artificial Organ And Bionics Market by Artificial Bionics Type
5.4.2 Rest of North America Artificial Organ And Bionics Market by Technology
Chapter 6. Company Profiles
6.1 Medtronic PLC
6.1.1 Company overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expenses
6.2 Boston Scientific Corporation
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 SWOT Analysis
6.3 Abiomed, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Regional Analysis
6.3.4 Research & Development Expenses
6.4 Berlin Heart GmbH
6.4.1 Company Overview
6.5 Jarvik Heart, Inc.
6.5.1 Company Overview
6.6 Zimmer Biomet Holdings, Inc.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 Cochlear Ltd.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Research & Development Expense
6.8 Ekso Bionics Holdings, Inc.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expenses
6.9 iWALKFree, Inc.
6.9.1 Company Overview
6.10. Edwards Lifesciences Corporation
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Regional Analysis
6.10.4 Research & Development Expenses
Unique Offerings 
